Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amgen (NQ: AMGN ) 337.38 +1.43 (+0.43%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 20, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Amgen < Previous 1 2 3 4 5 6 7 8 9 ... 40 41 Next > Can These 5 Assets Skyrocket Your Portfolio? September 22, 2024 Are Verizon, Amazon, Cisco, Amgen, and the S&P Biotech Bull 3X Shares ETF poised to make your portfolio skyrocket? In this video, I take a closer look. Via Talk Markets Topics ETFs Stocks Exposures US Equities Interesting Technical Analysis finding for AMGEN INC (NASDAQ:AMGN) September 20, 2024 NASDAQ:AMGN Shows Potential for a Breakout. Via Chartmill Where Will Amgen Be in 5 Years? September 20, 2024 There are plenty of ongoing positive developments with the biotech giant. Via The Motley Fool Behind the Scenes of Amgen's Latest Options Trends September 19, 2024 Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session September 18, 2024 Via Benzinga The Bull Market Strengthened, Let The Naysayers Say Nay... September 15, 2024 Being able to recite the potential problems in the world does not make you a good investor. Via Talk Markets (AMGN) - Analyzing Amgen's Short Interest September 03, 2024 Via Benzinga Amgen Unusual Options Activity For August 29 August 29, 2024 Via Benzinga Smart Money Is Betting Big In AMGN Options August 12, 2024 Via Benzinga Time To Invest And Or Trade In Bio-Tech Stocks? September 13, 2024 Biotechnology stocks and biotech exchange-traded funds ETFs once played a significant role in growth equity rallies, but today it seems like those days are in the past. Will an interest rate cut help... Via Talk Markets Topics ETFs 2 Unstoppable Growth Stocks to Buy Right Now for Less Than $500 September 13, 2024 Growth-oriented businesses can make excellent additions to a well-diversified portfolio. Via The Motley Fool Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now September 12, 2024 Amgen is a decently valued stock that has an excellent business and also gives investors a way to potentially gain exposure to a lucrative weight loss market. Via The Motley Fool UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars September 11, 2024 UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs. Via Benzinga Viridian Spikes On A 'Bull-Case Scenario' For Eye Drug Considered Amgen Rival September 10, 2024 The results are also promising for the next-generation version of that drug. Via Investor's Business Daily Growth At Any Price (GAAP) Is A Bad Strategy. Valuation Matters. September 08, 2024 The current leadership in the stock market is clearly not tech, or the Magnificent 7. Via Talk Markets Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern September 05, 2024 Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation. Other drugs also affected. Via Benzinga Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs September 03, 2024 Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly higher than those in other wealthy nations, with some prices still more than... Via Benzinga Topics Economy Exposures Interest Rates The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race August 29, 2024 The race to develop the next big obesity treatment is on with leaders Lilly and Novo trying to keep their top slots. Via Investor's Business Daily Patchy But Still Bullish September 02, 2024 Two weeks ago we turned to a more bullish stance, which has proved to be correct, though we still await the explosive movement out of these consolidations. Via Talk Markets Intuit, Amgen And Sprott Uranium Miners ETF: CNBC's 'Final Trades' August 29, 2024 Jason Snipe of Odyssey Capital Advisors likes Intuit Inc., after the company beat on the top and bottom lines, but missed on guidance. Via Benzinga Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug August 27, 2024 The single-dose vials will also increase supply, the drug giant says. Via Investor's Business Daily 3 Unstoppable Dividend Stocks to Buy Right Now August 25, 2024 These stocks are the A-team for income investors. Via The Motley Fool US Stocks May Take a Breather After S&P 500's Impressive 8-Session Winning Streak: Strategist Says Market Will Hit Fresh Highs In Next 4 Weeks, But Warns Investors Of Potential Risks August 20, 2024 The gravity-defying climb faces risk, as the index futures trade narrowly mixed in early trading on Tuesday. That said, the recent gains could keep traders wary of a potential pullback. Via Benzinga Topics Stocks Exposures US Equities ProInvestor Insights - August 2024 August 19, 2024 Our August newletter features insights from high-level Wall Street researchers, traders, analysts, and economists that you won’t find anywhere else. And AAII’s first-to-be-seen interview with legendary... Via Talk Markets 2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade August 18, 2024 Investors seeking reliable dividend growth want to start with these two members of the Dow Jones Industrial Average. Via The Motley Fool Topics Stocks Exposures US Equities This Healthcare Giant Had 12 Products That Generated Double-Digit Growth Last Quarter and There's Still Many More in the Pipeline August 17, 2024 Amgen has many growth opportunities ahead, and it also pays a fairly high dividend. Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session August 15, 2024 Via Benzinga Medicare Slashes Merck, Novo, AstraZeneca Drug Prices Up To 79% In IRA Negotiations August 15, 2024 The unveiled prices follow months of back-and-forth negotiation between the government and the companies. Via Investor's Business Daily Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review August 09, 2024 After Monday's panicked global sell-off, markets have calmed down. Via Investor's Business Daily The Defensive Sectors And VIX Have NOT Given The All-Clear Signal August 08, 2024 The market has been a rollercoaster lately, with the resilience of defensive sectors and the modest bounce in the technology sector painting an intriguing picture. Via Talk Markets Topics Stocks Exposures US Equities < Previous 1 2 3 4 5 6 7 8 9 ... 40 41 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.